Inhalation Sciences Abs (publ.) labtech system installed at University of Copenhagen for research into new inhalable TB vaccine.
STOCKHOLM, SWEDEN – August 23, 2017. The University of Copenhagen, Department of Pharmacy is to install PreciseInhale, ISAB’s advanced R&D labtech system, for its research into inhaled pharmaceutical therapies against TBC.Group Leader and Associate Professor at the Department, Camilla Foged: “Acquiring PreciseInhale will enable us to perform essential preclinical proof-of-concept immunogenicity, efficacy and toxicology studies of highly promising inhalable dry powder-based nanomedicine formulations that we have designed. Installing PreciseInhale in our labs at the Department of Pharmacy is